UNSPSC 51284402: Ceftobiprole

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5T97333YZK. European Medicines Agency schedules Ceftobiprole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25723. Ceftobiprole generally arises in the molecular formula C20H22N8O6S2. The term CEFTOBIPROLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19, no. 3, 2005, list 54.) Most nations schedule ceftobiprole under HS 29419000 and SITC 54139.

As of Q4 2014, CEFTOBIPROLE remains the US FDA Preferred Term for this commodity. Ceftobiprole bears US NLM identifiers UMLS ID C1100584 and NCI Concept Code C65306. SMILES: S1C2N(C(=O)C2NC(=O)C(=C2\[NH]SC(N2)N)\N=O)C(=C(C1)/C=C1\CCN(C2CCNC2)C1=O)C(=O)O.

UNSPSC 51284402 Ceftobiprole (Commodity) covers pharmaceutical products procured by state and local health agencies, though recent solicitations under this code tag show limited direct alignment with the antibiotic specified in the code name. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse cooperative purchasing vehicle to Chartwell Rx LLC in August 2026 for antibiotics (Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets) totaling $2.999 million over 12 months plus two optional renewal years under an Invitation for Bid process. State health departments and county public health authorities drive activity under this code, with procurement structured through cooperative purchasing frameworks to manage commodity pharmaceutical supply chains. Contracts typically run 12–24 months with renewal options and require vendor compliance with drug-free workplace and E-Verify requirements.

Illinois and Florida are the states with recent documented activity. The Seminole County, Florida procurement (IFB 60459723LAS, response deadline July 26, 2023) solicited 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, though this opportunity pre-dates the current date and reflects community health rather than antibiotic supply. The Illinois award represents the most recent and operationally relevant signal for cephalosporin or broad-spectrum antibiotic procurement at the state health-agency level. Cooperative purchasing piggyback awards remain the primary vehicle for pharmaceutical commodity procurement in this space, with pricing driven by competitive bidding and vendor selection favoring low-cost, responsive bidders. No set-aside designations or domestic-content preferences were applied in the Illinois award.